期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Systemic lupus erythematosus combined with primary hyperfibrinolysis and protein C and protein S deficiency:A case report
1
作者 Yi-Xuan Liao Yan-Fei Guo +2 位作者 Yu-Xia Wang Ai-Hua Liu Chun-Li Zhang 《World Journal of Clinical Cases》 SCIE 2021年第8期2008-2014,共7页
BACKGROUND Systemic lupus erythematosus(SLE)is an autoimmune disease characterized by systemic involvement and multiple autoantibodies in the serum.Patients with protein C(PC)and protein S(PS)deficiency are prone to t... BACKGROUND Systemic lupus erythematosus(SLE)is an autoimmune disease characterized by systemic involvement and multiple autoantibodies in the serum.Patients with protein C(PC)and protein S(PS)deficiency are prone to thrombosis.In contrast,patients with primary hyperfibrino-lysis tend to bleed.CASE SUMMARY A 52-year-old female patient with bilateral pleural effusion was diagnosed with"tuberculous pleurisy"and treated with anti-tuberculosis drugs and prednisone.The coagulation-related laboratory results showed decreased fibrinogen,PC activity,PS activity,and antithrombinШactivity.The immune-related laboratory results showed positive antinuclear antibody,anti-Smith antibody,anticardiolipin antibody(ACL),anti-β2-glycoprotein I antibody(aβ2GPI)and direct Coomb’s test and decreased complement 3 and complement 4.Thoracoscopy was performed and bloody pleural fluid was drained.Pathology of the pleural biopsy showed lymphocytes,plasma cells,and a few eosinophils in adipose and fibrous connective tissue.Results of whole exome sequencing of blood showed no genetic mutations suggesting the presence of hereditary hematological diseases.The patient was finally diagnosed with SLE and primary hyperfibrinolysis,and was treated with prednisolone,hydroxychloroquine,and compound cyclophosphamide.CONCLUSION PC and PS deficiency in SLE might be related to ACL and aβ2GPI.SLE and primary hyperfibrinolysis can coexist in one patient,with both a risk of thrombosis and a risk of bleeding. 展开更多
关键词 Systemic lupus erythematosus Primary hyperfibrinolysis Antiphospholipid antibody Protein C deficiency Protein S deficiency Case report
下载PDF
The pathogenesis of chronic subdural hematoma in the perspective of neomembrane formation and related mechanisms
2
作者 MINGYUE HUANG JUNFEI DAI +3 位作者 XIANLIANG ZHONG JIN WANG JIANZHONG XU BO DU 《BIOCELL》 SCIE 2024年第6期889-896,共8页
Chronic subdural hematoma(CSDH)is a disease characterized by capsuled blood products that progressively occupy the intracranial space,causing intracranial hypertension and compression in the brain.CSDH frequently occu... Chronic subdural hematoma(CSDH)is a disease characterized by capsuled blood products that progressively occupy the intracranial space,causing intracranial hypertension and compression in the brain.CSDH frequently occurs in all demographics,especially in the elderly,but the pathogenesis of CSDH remains unclear.In this review,we discuss the origin,development,and current treatment strategies of CSDH.For thefirst time,we analyzed the cellular and molecular compositions of hematoma membranes with a focus on neomembrane formation,a complex early-stage interactive event in hematoma pathogenesis.We hypothesize that in patients with CSDH,dural border cells(DBCs)might be induced to synthesize collagen or serum proteins might accumulate at the dura and arachnoid layers at the site of injury,thereby encapsulating the hemorrhage.Membrane formation may trigger inflammatory responses after subdural hemorrhage,promotingfibroblast-involved extracellular matrix(ECM)deposition and aberrant angiogenesis within the outer membrane.Consequently,ECM deposition and angiogenesis mutually influence each other and are modulated by inflammatory processes.By illustrating the complex and interactive mechanism of neomembrane formation,we aim to provide a novel insight into CSDH pathogenesis and propose directions for future research as well as advancements in treatment strategies for this disease. 展开更多
关键词 Chronic subduralhematoma Inflammation ANGIOGENESIS Extracellular matrix hyperfibrinolysis
下载PDF
High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis 被引量:20
3
作者 Aldo Spadaro Vincenza Tortorella +9 位作者 Carmela Morace Agostino Fortiguerra Paola Composto Caterina Bonfiglio Angela Alibrandi Carmelo Luigiano Giuseppe De Caro Antonino Ajello Oscar Ferraù Maria Antonietta Freni 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第10期1549-1552,共4页
AIM: To measure plasma D-dimer levels in cirrhotic patients with and without ascites, assessing the effect of ascites resolution in D-dimer concentration. METHODS: Seventy consecutive cirrhotic patients (M = 44, F = 2... AIM: To measure plasma D-dimer levels in cirrhotic patients with and without ascites, assessing the effect of ascites resolution in D-dimer concentration. METHODS: Seventy consecutive cirrhotic patients (M = 44, F = 26, mean age 65 years, SD ± 13), observed from October 2005 to March 2006 were enrolled. Circulating D-dimer levels were measured using a latex-enhanced, immunoturbidimetric test. In patients with ascites (n = 42) the test was repeated after ascites resolution. RESULTS: Ascites was present in 42 patients (group A) and absent in 28 (group B). Group A patients had more advanced liver disease. Hepatocellular carcinoma (HCC) was diagnosed in 14 patients and was more frequent in group B. Above normal range D-dimers were found in 45/70 patients. High D-dimers were more frequent in group A than in group B (P = 0.001). High D-dimers were associated with presence of HCC (P = 0.048) only in group B. After ascites resolution, obtained in all patients, mean D-dimer values decreased in those 34 patients with high basal levels (P = 0.007), returning to normal in 17. CONCLUSION: In patients with liver cirrhosis, ascites and HCC are the main factors associated with increased fibrinolytic activity. 展开更多
关键词 D-DIMERS Liver cirrhosis ASCITES Hepatocellular carcinoma hyperfibrinolysis
下载PDF
Effect of sub-hypothermia therapy on coagulopathy after severe head injury 被引量:5
4
作者 LI Gang XU Ru-xiang +4 位作者 KE Yi-quan JIANG Xiao-dan ZHANG Shu-fen DENG Bi-lan YU Xing 《Chinese Medical Journal》 SCIE CAS CSCD 2008年第22期2350-2352,共3页
Sub-hypothermia therapy is one of the treatments for patients with severe head injury. The objective of the therapy is to treat traumatic brain injury (TBI) by alleviating brain edema, protecting blood brain barrier... Sub-hypothermia therapy is one of the treatments for patients with severe head injury. The objective of the therapy is to treat traumatic brain injury (TBI) by alleviating brain edema, protecting blood brain barrier (BBB), and preventing subsequent damage to neurons. It can protect brain function by depressing metabolism, reducing the release of excitatory amino acids and free radicals, reducing the level of lactic acid, and lowering the damage of cytoskeletal structure However, 展开更多
关键词 sub-hypothermia brain injury blood coagulation hyperfibrinolysis
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部